Filing Details
- Accession Number:
- 0000905148-19-001001
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-18 17:20:16
- Reporting Period:
- 2019-11-18
- Accepted Time:
- 2019-11-18 17:20:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1358762 | Reata Pharmaceuticals Inc | RETA | Pharmaceutical Preparations (2834) | 113651945 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1372218 | Cpmg Inc | 2000 Mckinney Ave., Ste 2125 Dallas TX 75201 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2019-11-18 | 7,104 | $183.00 | 116,512 | No | 4 | P | Indirect | By Nighthawk Partners, LP |
| Class A Common Stock | Acquisiton | 2019-11-18 | 328 | $183.00 | 282,246 | No | 4 | P | Indirect | By Willet Fund, LP |
| Class A Common Stock | Acquisiton | 2019-11-18 | 27,322 | $183.00 | 137,962 | No | 4 | P | Indirect | By Killdeer Fund, LP |
| Class A Common Stock | Acquisiton | 2019-11-18 | 5,464 | $183.00 | 5,464 | No | 4 | P | Indirect | By Elepaio Partners, LP |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Nighthawk Partners, LP |
| No | 4 | P | Indirect | By Willet Fund, LP |
| No | 4 | P | Indirect | By Killdeer Fund, LP |
| No | 4 | P | Indirect | By Elepaio Partners, LP |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Class A Common Stock | 44,200 | Indirect | By Barred Owl Partners, LP |
| Class A Common Stock | 34,897 | Indirect | By Managed Account for Trustees of the University of Pennsylvania |
| Class A Common Stock | 442,560 | Indirect | By Gallopavo, LP |
| Class A Common Stock | 748,253 | Indirect | By Roadrunner Fund, LP |
| Class A Common Stock | 103,185 | Indirect | By Blackwell Partners LLC |
| Class A Common Stock | 431,155 | Indirect | By Yellow Warbler, LP |
| Class A Common Stock | 109,415 | Indirect | By Mallard Fund, LP |
| Class A Common Stock | 37,909 | Indirect | By Crested Crane, LP |
| Class A Common Stock | 63,481 | Indirect | By Flamingo Fund, LP |
| Class A Common Stock | 334,740 | Indirect | By Sandpiper Fund, LP |
| Class A Common Stock | 160,265 | Indirect | By Kestrel Fund, LP |
| Class A Common Stock | 11,076 | Indirect | By CD Fund, LP |
| Class A Common Stock | 134 | Indirect | By Redbird Life Sciences Partners, LP |
| Class A Common Stock | 113 | Direct |
Footnotes
- The Reporting Person is the investment manager of each of: Nighthawk Partners, LP; Killdeer Fund, LP; Willet Fund, LP; Elepaio Partners, LP; Barred Owl Partners, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Billionaire Hedge Funds
